ATH 0.00% 0.3¢ alterity therapeutics limited

another study implicating copper in ad

  1. 1,300 Posts.
    lightbulb Created with Sketch. 6
    All taped up IMHO

    Abstract from

    http://www.ncbi.nlm.nih.gov/pubmed/24435851

    Biometals. 2014 Jan 17. [Epub ahead of print]
    Predictive association of copper metabolism proteins with Alzheimer's disease and Parkinson's disease: a preliminary perspective.
    Pal A, Kumar A, Prasad R.
    Author information

    Abstract
    Neurodegenerative diseases, Alzheimer's disease (AD) and Parkinson's disease (PD), constitute a major worldwide health problem. Several hypothesis have been put forth to elucidate the basis of onset and pathogenesis of AD and PD; however, till date, none of these seems to clearly elucidate the complex pathoetiology of these disorders. Notably, copper dyshomeostasis has been shown to underlie the pathophysiology of several neurodegenerative diseases including AD and PD. Numerous studies have concluded beyond doubt that imbalance in copper homeostatic mechanisms in conjunction with aging causes an acceleration in the copper toxicity elicited oxidative stress, which is detrimental to the central nervous system. Amyloid precursor protein and a-synuclein protein involved in AD and PD are copper binding proteins, respectively. In this review, we have discussed the possible association of copper metabolism proteins with AD and PD along with briefly outlining the expanding proportion of "copper interactome" in human biology. Using network biology, we found that copper metabolism proteins, superoxide dismutase 1 and ceruloplasmin may represent direct and indirect link with AD and PD, respectively.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $15.96M
Open High Low Value Volume
0.3¢ 0.4¢ 0.3¢ $12.53K 4.143M

Buyers (Bids)

No. Vol. Price($)
3 13926044 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 153031722 56
View Market Depth
Last trade - 14.56pm 19/11/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.